<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Low life

Low life

1 October 2015

1:00 PM

1 October 2015

1:00 PM

Every morning for the past two years, on waking, I’ve reached out for the white plastic tub on the bedside table, shaken out four oval white tablets into the lid, tossed them into my mouth, and washed them down with a pint of water. Initially I counted myself lucky to be selected to take the expensive drug abiraterone for two years as part of a nationwide clinical trial.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER


Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Low life

Low life

1 October 2015

1:00 PM

1 October 2015

1:00 PM

Every morning for the past two years, on waking, I’ve reached out for the white plastic tub on the bedside table, shaken out four oval white tablets into the lid, tossed them into my mouth, and washed them down with a pint of water. Initially I counted myself lucky to be selected to take the expensive drug abiraterone for two years as part of a nationwide clinical trial.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER


Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close